BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 10223227)

  • 1. The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas.
    Nakajima M; Sawada H; Yamada Y; Watanabe A; Tatsumi M; Yamashita J; Matsuda M; Sakaguchi T; Hirao T; Nakano H
    Cancer; 1999 May; 85(9):1894-902. PubMed ID: 10223227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas.
    Carneiro F; Sobrinho-Simoes M
    Cancer; 2000 Jan; 88(1):238-40. PubMed ID: 10618628
    [No Abstract]   [Full Text] [Related]  

  • 3. c-erb B-2 expression is associated with tumor location and venous invasion and influences survival of patients with gastric carcinoma.
    Pinto-de-Sousa J; David L; Almeida R; Leitão D; Preto JR; Seixas M; Pimenta A
    Int J Surg Pathol; 2002 Oct; 10(4):247-56. PubMed ID: 12490974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification of the c-met, c-erbB-2 and epidermal growth factor receptor gene in human gastric cancers: correlation to clinical features.
    Tsugawa K; Yonemura Y; Hirono Y; Fushida S; Kaji M; Miwa K; Miyazaki I; Yamamoto H
    Oncology; 1998; 55(5):475-81. PubMed ID: 9732228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification and overexpression of c-met gene in Epstein-Barr virus-associated gastric carcinomas.
    Kijima Y; Hokita S; Yoshinaka H; Itoh T; Koriyama C; Eizuru Y; Akiba S; Aikou T
    Oncology; 2002; 62(1):60-5. PubMed ID: 11810045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma.
    Zhang J; Guo L; Liu X; Li W; Ying J
    Oncotarget; 2017 Feb; 8(6):10264-10273. PubMed ID: 28052014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of MET amplification on gastric cancer: possible roles as a novel prognostic marker and a potential therapeutic target.
    Lee J; Seo JW; Jun HJ; Ki CS; Park SH; Park YS; Lim HY; Choi MG; Bae JM; Sohn TS; Noh JH; Kim S; Jang HL; Kim JY; Kim KM; Kang WK; Park JO
    Oncol Rep; 2011 Jun; 25(6):1517-24. PubMed ID: 21424128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-erb B2 (Her2/neu) is neither overexpressed nor amplified in hepatic neoplasms.
    Vlasoff DM; Baschinsky DY; De Young BR; Morrison CD; Nuovo GJ; Frankel WL
    Appl Immunohistochem Mol Morphol; 2002 Sep; 10(3):237-41. PubMed ID: 12373150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MET is overexpressed in microsatellite instability-high gastric carcinoma.
    Sim J; Heo YJ; Bae H; Shin HC; Kim B; Cho J; Kim ST; Lee J; Kang WK; Kim KM
    Pathol Res Pract; 2019 Mar; 215(3):433-438. PubMed ID: 30455128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis.
    Kim HS; Chon HJ; Kim H; Shin SJ; Wacheck V; Gruver AM; Kim JS; Rha SY; Chung HC
    J Surg Oncol; 2018 Jun; 117(8):1679-1686. PubMed ID: 29790169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of the c-met protooncogene in human gastric carcinoma--correlation to clinical features.
    Huang TJ; Wang JY; Lin SR; Lian ST; Hsieh JS
    Acta Oncol; 2001; 40(5):638-43. PubMed ID: 11669338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of MET protein overexpression and gene amplification in locoregionally advanced nasopharyngeal carcinoma.
    Li Y; Li W; He Q; Xu Y; Ren X; Tang X; Wen X; Yang X; Sun Y; Zeng J; Yun J; Liu N; Ma J
    Oncotarget; 2015 May; 6(15):13309-19. PubMed ID: 25965822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene amplification and proliferative kinetics in relation to prognosis of patients with gastric carcinoma.
    Amadori D; Maltoni M; Volpi A; Nanni O; Scarpi E; Renault B; Pellegata NS; Gaudio M; Magni E; Ranzani GN
    Cancer; 1997 Jan; 79(2):226-32. PubMed ID: 9010095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma.
    Catenacci DV; Ang A; Liao WL; Shen J; O'Day E; Loberg RD; Cecchi F; Hembrough T; Ruzzo A; Graziano F
    Cancer; 2017 May; 123(6):1061-1070. PubMed ID: 27926778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
    Nakazawa K; Dobashi Y; Suzuki S; Fujii H; Takeda Y; Ooi A
    J Pathol; 2005 Jul; 206(3):356-65. PubMed ID: 15892172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocrine motility factor receptor, and urokinase-type plasminogen activator receptor.
    Taniguchi K; Yonemura Y; Nojima N; Hirono Y; Fushida S; Fujimura T; Miwa K; Endo Y; Yamamoto H; Watanabe H
    Cancer; 1998 Jun; 82(11):2112-22. PubMed ID: 9610690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas.
    Ha SY; Lee J; Kang SY; Do IG; Ahn S; Park JO; Kang WK; Choi MG; Sohn TS; Bae JM; Kim S; Kim M; Kim S; Park CK; Ignatius Ou SH; Kim KM
    Mod Pathol; 2013 Dec; 26(12):1632-41. PubMed ID: 23807774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.
    Fuse N; Kuboki Y; Kuwata T; Nishina T; Kadowaki S; Shinozaki E; Machida N; Yuki S; Ooki A; Kajiura S; Kimura T; Yamanaka T; Shitara K; Nagatsuma AK; Yoshino T; Ochiai A; Ohtsu A
    Gastric Cancer; 2016 Jan; 19(1):183-91. PubMed ID: 25682441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The prognostic significance of expression of c-met oncogene and its relation to gastric mucosal lesions].
    Zhuang X; Zheng J; Lin S; Sun G; Li Y
    Zhonghua Bing Li Xue Za Zhi; 2000 Dec; 29(6):409-11. PubMed ID: 11866940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of CD44 and c-erb-B2 protein overexpression in patients with gastric cancer.
    Doventas A; Bilici A; Demirell F; Ersoy G; Turna H; Doventas Y
    Hepatogastroenterology; 2012 Oct; 59(119):2196-201. PubMed ID: 23435135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.